FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078663053> ?p ?o ?g. }

• W2078663053 endingPage "312" @default.
• W2078663053 startingPage "302" @default.
• W2078663053 abstract "Moxalactam (6059-S) {7β-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7α-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]-methyl]-1-oxa-1-dethia-3-cephem-4- carboxylic acid disodium salt} is a new semisynthetic 1-oxa-β-lactam derivative for parenteral use. It was highly active against a broad range of gram-negative microorganisms, including those resistant to other cephalosporins. Moreover, it had widely expanded antibacterial spectra which included Haemophilus influenzae , indole-positive Proteus, Enterobacter, Serratia marcescens, Pseudomonas aeruginosa , and Bacteroides fragilis . When a large number of clinical isolates of the above-named bacilli were tested by the agar dilution method, using an inoculum size of one loopful of 10 6 or 10 8 organisms or both per ml, the 70% minimal inhibitory concentrations at the lower inoculum were 0.2, 0.2, 0.4, 0.8, 25, and 0.8 μg/ml, respectively. Its activity appeared to be independent of inoculum size and addition of serum. In these organisms, morphological response of the exposed cells revealed that the bacteriolytic effect of 6059-S was initiated by a concentration equivalent to the minimal inhibitory concentration. 6059-S was markedly bactericidal to both β-lactamase-producing and -nonproducing strains of Escherichia coli ; this was well reflected by its extraordinary stability to microbial β-lactamase degradation. Administered subcutaneously in mice, 6059-S attained plasma levels and a half-life similar to those of cefazolin and exhibited potent protective efficacy against systemic infections; it also proved to be significantly more effective than either sulbenicillin or piperacillin against Pseudomonas aeruginosa and than either cefazolin or cefmetazole against a variety of other gram-negative bacteria." @default.
• W2078663053 created "2016-06-24" @default.
• W2078663053 creator A5032861920 @default.
• W2078663053 creator A5044397980 @default.
• W2078663053 creator A5045616690 @default.
• W2078663053 creator A5058995502 @default.
• W2078663053 creator A5080255427 @default.
• W2078663053 date "1980-03-01" @default.
• W2078663053 modified "2023-10-18" @default.
• W2078663053 title "Moxalactam (6059-S), a Novel 1-Oxa-β-Lactam with an Expanded Antibacterial Spectrum: Laboratory Evaluation" @default.
• W2078663053 cites W1499482268 @default.
• W2078663053 cites W1978184644 @default.
• W2078663053 cites W1978232051 @default.
• W2078663053 cites W1987634568 @default.
• W2078663053 cites W1990645015 @default.
• W2078663053 cites W1992033814 @default.
• W2078663053 cites W1992230812 @default.
• W2078663053 cites W2030962977 @default.
• W2078663053 cites W2078639295 @default.
• W2078663053 cites W2084655721 @default.
• W2078663053 cites W2085753293 @default.
• W2078663053 cites W2089683281 @default.
• W2078663053 cites W2094836436 @default.
• W2078663053 cites W2291110813 @default.
• W2078663053 cites W2326392126 @default.
• W2078663053 doi "https://doi.org/10.1128/aac.17.3.302" @default.
• W2078663053 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/283781" @default.
• W2078663053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6448572" @default.
• W2078663053 hasPublicationYear "1980" @default.
• W2078663053 type Work @default.
• W2078663053 sameAs 2078663053 @default.
• W2078663053 citedByCount "73" @default.
• W2078663053 crossrefType "journal-article" @default.
• W2078663053 hasAuthorship W2078663053A5032861920 @default.
• W2078663053 hasAuthorship W2078663053A5044397980 @default.
• W2078663053 hasAuthorship W2078663053A5045616690 @default.
• W2078663053 hasAuthorship W2078663053A5058995502 @default.
• W2078663053 hasAuthorship W2078663053A5080255427 @default.
• W2078663053 hasBestOaLocation W20786630532 @default.
• W2078663053 hasConcept C104317684 @default.
• W2078663053 hasConcept C185592680 @default.
• W2078663053 hasConcept C2776309202 @default.
• W2078663053 hasConcept C2776368647 @default.
• W2078663053 hasConcept C2776925733 @default.
• W2078663053 hasConcept C2777637488 @default.
• W2078663053 hasConcept C2778193466 @default.
• W2078663053 hasConcept C2778353156 @default.
• W2078663053 hasConcept C2778983983 @default.
• W2078663053 hasConcept C2779074116 @default.
• W2078663053 hasConcept C2779609581 @default.
• W2078663053 hasConcept C2779631663 @default.
• W2078663053 hasConcept C2779766023 @default.
• W2078663053 hasConcept C2780246119 @default.
• W2078663053 hasConcept C2780416669 @default.
• W2078663053 hasConcept C2909971615 @default.
• W2078663053 hasConcept C501593827 @default.
• W2078663053 hasConcept C523546767 @default.
• W2078663053 hasConcept C54355233 @default.
• W2078663053 hasConcept C547475151 @default.
• W2078663053 hasConcept C55493867 @default.
• W2078663053 hasConcept C64778159 @default.
• W2078663053 hasConcept C71924100 @default.
• W2078663053 hasConcept C86803240 @default.
• W2078663053 hasConcept C89423630 @default.
• W2078663053 hasConcept C94665300 @default.
• W2078663053 hasConceptScore W2078663053C104317684 @default.
• W2078663053 hasConceptScore W2078663053C185592680 @default.
• W2078663053 hasConceptScore W2078663053C2776309202 @default.
• W2078663053 hasConceptScore W2078663053C2776368647 @default.
• W2078663053 hasConceptScore W2078663053C2776925733 @default.
• W2078663053 hasConceptScore W2078663053C2777637488 @default.
• W2078663053 hasConceptScore W2078663053C2778193466 @default.
• W2078663053 hasConceptScore W2078663053C2778353156 @default.
• W2078663053 hasConceptScore W2078663053C2778983983 @default.
• W2078663053 hasConceptScore W2078663053C2779074116 @default.
• W2078663053 hasConceptScore W2078663053C2779609581 @default.
• W2078663053 hasConceptScore W2078663053C2779631663 @default.
• W2078663053 hasConceptScore W2078663053C2779766023 @default.
• W2078663053 hasConceptScore W2078663053C2780246119 @default.
• W2078663053 hasConceptScore W2078663053C2780416669 @default.
• W2078663053 hasConceptScore W2078663053C2909971615 @default.
• W2078663053 hasConceptScore W2078663053C501593827 @default.
• W2078663053 hasConceptScore W2078663053C523546767 @default.
• W2078663053 hasConceptScore W2078663053C54355233 @default.
• W2078663053 hasConceptScore W2078663053C547475151 @default.
• W2078663053 hasConceptScore W2078663053C55493867 @default.
• W2078663053 hasConceptScore W2078663053C64778159 @default.
• W2078663053 hasConceptScore W2078663053C71924100 @default.
• W2078663053 hasConceptScore W2078663053C86803240 @default.
• W2078663053 hasConceptScore W2078663053C89423630 @default.
• W2078663053 hasConceptScore W2078663053C94665300 @default.
• W2078663053 hasIssue "3" @default.
• W2078663053 hasLocation W20786630531 @default.
• W2078663053 hasLocation W20786630532 @default.
• W2078663053 hasLocation W20786630533 @default.
• W2078663053 hasOpenAccess W2078663053 @default.
• W2078663053 hasPrimaryLocation W20786630531 @default.
• W2078663053 hasRelatedWork W155962051 @default.

• next